BioNTech SE (BNTX) Interest Coverage Ratio (QoQ) (2018 - 2025)
BioNTech SE (BNTX) Interest Coverage Ratio (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,029.64% |
| Sep 30, 2025 | -97.40% |
| Jun 30, 2025 | 354.36% |
| Mar 31, 2025 | 233.59% |
| Dec 31, 2024 | -798.56% |
| Sep 30, 2024 | -100.99% |
| Jun 30, 2024 | 22.65% |
| Mar 31, 2024 | 616.81% |
| Dec 31, 2023 | 42.87% |
| Sep 30, 2023 | -108.44% |
| Jun 30, 2023 | 2,020.22% |
| Mar 31, 2023 | -9.03% |
| Dec 31, 2022 | 97.21% |
| Sep 30, 2022 | 9.43% |
| Jun 30, 2022 | -0.61% |
| Mar 31, 2022 | -5.72% |
| Dec 31, 2021 | -1,248.91% |
| Sep 30, 2021 | -339.30% |
| Jun 30, 2021 | -35.81% |
| Mar 31, 2021 | 576.10% |